Development and pilot of the Alcohol and Depression Decision-Aid for Psychological Treatments (ADDAPT)

IF 0.8 Q4 PSYCHOLOGY, CLINICAL Advances in Dual Diagnosis Pub Date : 2023-03-07 DOI:10.1108/add-10-2022-0028
A. Fisher, Sylvia Eugene Dit Rochesson, Logan R Harvey, Christina Marel, K. Mills
{"title":"Development and pilot of the Alcohol and Depression Decision-Aid for Psychological Treatments (ADDAPT)","authors":"A. Fisher, Sylvia Eugene Dit Rochesson, Logan R Harvey, Christina Marel, K. Mills","doi":"10.1108/add-10-2022-0028","DOIUrl":null,"url":null,"abstract":"\nPurpose\nEvidence is lacking as to the superiority of dual-focused versus single-focused approaches in treating depression and alcohol use comorbidity. Different people may also value the different features of treatment options differently, necessitating a decision-support tool. This study aims to test the acceptability, feasibility, safety and potential usefulness of the Alcohol and Depression Decision-Aid for Psychological Treatments (ADDAPT).\n\n\nDesign/methodology/approach\nADDAPT was developed according to International Patient Decision-Aid Standards and in consultation with potential end users. Adults with depression and alcohol use comorbidity, who were considering/recently considered psychological treatments, were recruited via online advertisements. After clicking on the study URL, participants accessed the ADDAPT e-book and completed validated and purpose-designed questionnaires.\n\n\nFindings\nOf the 24 participants, most would recommend ADDAPT to others (79.2% agree) and endorsed it as easy-to-use (75%), useful in decision-making (79.2%), presenting balanced (87.5%), up-to-date (91.7%), easy-to-understand (79.2%) and trustworthy information (83.3%), which did not provoke anxiety (i.e. safety; 75%). Post-use, participants felt well prepared to decide on treatment (M = 3.48/5) and demonstrated good treatment knowledge (M = 65.83%). All but one participant indicated a treatment choice supported by best available evidence, and decisional conflict scores except for the uncertainty subscale were below the threshold for decisional delay (all M < 37.5/100).\n\n\nOriginality/value\nADDAPT is the first decision-aid of its kind, with pilot findings supporting its acceptability, feasibility, safety and potential usefulness for improving decision-making quality among people considering psychological treatment options for depression and alcohol use comorbidity.\n","PeriodicalId":51922,"journal":{"name":"Advances in Dual Diagnosis","volume":"208 1","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2023-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Dual Diagnosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1108/add-10-2022-0028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose Evidence is lacking as to the superiority of dual-focused versus single-focused approaches in treating depression and alcohol use comorbidity. Different people may also value the different features of treatment options differently, necessitating a decision-support tool. This study aims to test the acceptability, feasibility, safety and potential usefulness of the Alcohol and Depression Decision-Aid for Psychological Treatments (ADDAPT). Design/methodology/approach ADDAPT was developed according to International Patient Decision-Aid Standards and in consultation with potential end users. Adults with depression and alcohol use comorbidity, who were considering/recently considered psychological treatments, were recruited via online advertisements. After clicking on the study URL, participants accessed the ADDAPT e-book and completed validated and purpose-designed questionnaires. Findings Of the 24 participants, most would recommend ADDAPT to others (79.2% agree) and endorsed it as easy-to-use (75%), useful in decision-making (79.2%), presenting balanced (87.5%), up-to-date (91.7%), easy-to-understand (79.2%) and trustworthy information (83.3%), which did not provoke anxiety (i.e. safety; 75%). Post-use, participants felt well prepared to decide on treatment (M = 3.48/5) and demonstrated good treatment knowledge (M = 65.83%). All but one participant indicated a treatment choice supported by best available evidence, and decisional conflict scores except for the uncertainty subscale were below the threshold for decisional delay (all M < 37.5/100). Originality/value ADDAPT is the first decision-aid of its kind, with pilot findings supporting its acceptability, feasibility, safety and potential usefulness for improving decision-making quality among people considering psychological treatment options for depression and alcohol use comorbidity.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心理治疗酒精与抑郁决策辅助工具(ADDAPT)的研制与试点
目的:在治疗抑郁症和酒精使用合并症方面,双焦点与单焦点方法的优越性尚缺乏证据。不同的人也可能对治疗方案的不同特征有不同的评价,这就需要一个决策支持工具。本研究旨在检验酒精与抑郁心理治疗决策辅助工具(ADDAPT)的可接受性、可行性、安全性和潜在有用性。设计/方法/方法daddapt是根据国际患者决策辅助标准并与潜在最终用户协商制定的。正在考虑或最近正在考虑心理治疗的患有抑郁症和酒精使用合并症的成年人通过在线广告被招募。在点击研究URL后,参与者访问了ADDAPT电子书,并完成了经过验证和目的设计的问卷。在24名参与者中,大多数人会向他人推荐ADDAPT(79.2%同意),并认为它易于使用(75%),在决策中有用(79.2%),呈现平衡(87.5%),最新(91.7%),易于理解(79.2%)和值得信赖的信息(83.3%),不会引起焦虑(即安全;75%)。使用后,参与者对决定治疗有充分的准备(M = 3.48/5),并表现出良好的治疗知识(M = 65.83%)。除一名参与者外,所有参与者都表示有最佳可用证据支持的治疗选择,除不确定性子量表外,决策冲突得分均低于决策延迟阈值(所有M < 37.5/100)。addapt是同类产品中的首个决策辅助工具,试点结果支持其可接受性、可行性、安全性以及在考虑抑郁症和酒精使用合并症的心理治疗选择的人群中提高决策质量的潜在有用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Advances in Dual Diagnosis
Advances in Dual Diagnosis PSYCHOLOGY, CLINICAL-
CiteScore
1.50
自引率
33.30%
发文量
15
期刊最新文献
The needs of carers who support people living with schizophrenia and a substance use disorder: a multiperspective evaluation Combating stigma: development and implementation of an education resource on older adults behavioral health challenges Positive addiction recovery therapy: a replication and follow-up study Repetitive transcranial magnetic stimulation implementation within residential substance use disorder treatment centers for patients with comorbid depression Addiction recovery stories: Bradley Maguire in conversation with Lisa Ogilvie
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1